Mitogen-stimulated DAT: a new method for the ... - Blood Transfusion

W Barcellini et al.References1) Biagi E, Assali G, Rossi F, et al. A persistent severe autoimmune hemolytic anemia despite apparent direct antiglobulin testnegativization. Haematologica 1999; 84: 1043-5.2) Garratty G. In: Immunobiology of Transfusion Medicine. New York:Marcel Dekker; 1994.3) Petz LD and Garratty G. Acquired Immune Hemolytic Anemias, New York, Churchill Livingstone; 1980.4) Dacie JV. The Autoimmune Haemolytic Anaemias. In: The Haemolytic Anaemias. Vol. 3, 3 rd Ed, New York, Churchill Livingstone1992.5) Sokol RJ, Hewitt S, Booker DJ, Stamps R. Enzyme linked direct antiglobulin tests in patients with autoimmune haemolysis. JClin Pathol 1985; 38: 912-4.6) Gilliland BC. Coombs-negative immune hemolytic anemia. Sem. Hematol 1976; 13: 267-75.7) Garratty G. In: Immune Destruction of Red Blood Cells, Arlington, VA, Am Assoc Blood Banks; 1989.8) Sokol RJ, Hewitt S, Booker DJ, Stamps R. Small quantities of erythrocyte bound immunoglobulins and autoimmune haemolysis.J Clin Pathol 1987; 40: 254-7.9) Gallagher MT, Branch DR, Mison A, Petz LD. Evaluation of reticuloendothelial function in autoimmune hemolytic anemia usingan in vitro assay of monocyte-macrophage interaction with erythrocytes Exp Hematol 1983; 11: 82-9.10) Garratty G. The clinical significance (and insignificance) of red-cell-bound IgG and complement. In: Wallance ME, Levitt JS,editors. Current Applications and Interpretation of the Direct Antiglobulin Test, Arlington, Am Assoc Blood Banks; 1988; 1-24.11) Leikola J, Perkins HA. Enzyme-linked antiglobulin test: an accurate and simple method to quantify red cell antibodies. Transfusion1980; 20: 138-44.12) Rebulla P. A biotin-avidin micro-ELISA antiglobulin test. Transfusion 1988; 28 (Suppl): 41-4.13) Wang Z, Shi J, Zhou Y, Ruan C. Detection of red blood cell-bound immunoglobulin G by flow cytometry and its application in thediagnosis of autoimmune hemolytic anemia. Int J Hematol 2001; 73: 188-93.14) Schmitz N, Djibey I, Kretschmer V, et al. Assessment of red cell autoantibodies in autoimmune hemolytic anemia of warm typeby a radioactive anti-IgG test. Vox Sang 1981; 41: 224-30.15) Rachel JM, Sinor LT, Beck ML, Plapp FV. A solid phase antiglobulin test. Transfusion 1985; 25: 24-6.16) Engelfriet CP, Overbeeke MA, von dem Borne AE. The antiglobulin test (Coombs test) and the red cell. In: Cash JD, editor,Progress in Transfusion Medicine, Churchill Livingstone, 1987; 2:74-98.17) Barcellini W, Clerici G, Montesano R, et al. In vitro quantification of anti-red blood cell antibody production in idiopathicautoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation. Br J Haematol 2000; 111: 452-60.18) Mauro FR, Foa R, Cerretti R, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, andprognostic features. Blood 2000; 95: 2786-92.19) Barcellini W, Montesano R, Clerici G, et al. In vitro production of anti-RBC antibodies and cytokines in chronic lymphocyticleukemia. Am J Hematol 2002; 71: 177-83.20) Walker RH. Technical Manual, 12th ed., Arlington, VA, Am Ass Blood Banks; 1996.21) Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored working group guidelines for chronic lymphocyticleukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-7.22) Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from amultivariate survival analysis. Cancer 1981; 48: 198-206.23) Shvidel L, Shtarlid M, Klepfish A, et al. Evans syndrome complicating fludarabine treatment for advanced B-CLL. Br J Haematol1997; 99: 706.24) Tertian G, Cartron J, Bayle C, et al. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chroniclymphocytic leukemia. Hematol Cell Ther 1996; 38: 359-60.25) Gonzalez H, Leblond V, Azar N, et al. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. HematolCell Ther 1998; 40: 113-8.26) Vick DJ, Byrd JC, Beal CL, Chaffin DJ. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patientwith chronic lymphocytic leukemia/small cell lymphoma. Vox Sang 1998; 74: 122-6136Blood Transf 2003; 2: 127-36